rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

ARCH Venture Partners XIV, L.P.

10% owner

Company insider

Files Form 4 as: 10% owner, Aspen Neuroscience.

In numbers

Trades disclosed
1
Buys
1
Sells
0
Bought
$18.0M
Sold
$0
Companies
1
Companies where not an officer
1
First trade
2 Nov 2026
Last trade
2 Nov 2026
Last filed
2 Nov 2026

Companies traded

Everywhere else they filed: board seats, 10% stakes, other companies
ASPE Aspen Neuroscience10% owner · Biotechnology · last 2 Nov 20261 buy · 0 sells

Activity over time

Not enough dated trades to draw.

Every trade

TradedCompanyWhatAmount
2 Nov 2026filed 2 Nov 2026ASPE Aspen NeuroscienceBiotechnologySEC FORM 4 Bought$18.0M1,200,000 at $15.00filing

News

Aspen Neuroscience (ASPE) raises $140.6 million in Nasdaq IPO at $15ASPE · 247wallst.com · 30 Oct 2026

0 headlines in the last 90 days name ARCH Venture Partners XIV, L.P.; 1 article from the last 14 days about the 1 company they traded most, at most three about any one of them.

Sectors

Health Care1

Buys in green, sells in red, by the company’s sector.

Related people

Faheem HasnainExecutive Chair · Executive Chair at Aspen Neuroscience, filing Form 4 there in the last year
ARCH Venture Fund X, L.P.10% owner · 10% owner at Aspen Neuroscience, filing Form 4 there in the last year
Andrew SpaventaDirector · Director at Aspen Neuroscience, filing Form 4 there in the last year